BioCentury
ARTICLE | Distillery Therapeutics

Cancer

January 11, 2017 4:37 PM UTC

Mouse studies suggest inhibiting NR1I3 could help prevent circadian disruption-induced hepatocellular carcinoma (HCC). The mouse model of chronic circadian disruption involved switching light and dark...